Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ingle, James N."" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł:
A comprehensive analysis of breast cancer microbiota and host gene expression.
Autorzy:
Thompson KJ; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Ingle JN; Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.
Tang X; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Chia N; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.; Department of Surgery, Mayo Clinic, Rochester, Minnesota, United States of America.
Jeraldo PR; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.; Department of Surgery, Mayo Clinic, Rochester, Minnesota, United States of America.
Walther-Antonio MR; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.; Department of Surgery, Mayo Clinic, Rochester, Minnesota, United States of America.
Kandimalla KK; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, United States of America.
Johnson S; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Yao JZ; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Harrington SC; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Suman VJ; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Wang L; Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
Weinshilboum RL; Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
Boughey JC; Department of Surgery, Mayo Clinic, Rochester, Minnesota, United States of America.
Kocher JP; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Nelson H; Department of Surgery, Mayo Clinic, Rochester, Minnesota, United States of America.
Goetz MP; Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.
Kalari KR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.; Department of Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Nov 30; Vol. 12 (11), pp. e0188873. Date of Electronic Publication: 2017 Nov 30 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression*
Breast Neoplasms/*microbiology
Breast Neoplasms/genetics ; Breast Neoplasms/immunology ; Breast Neoplasms/pathology ; Female ; Humans ; Proteobacteria ; RNA, Ribosomal, 16S/genetics ; Sequence Analysis, RNA ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.
Autorzy:
Cairns J; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
Ingle JN; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.
Wickerham LD; Section of Cancer Genetics and Prevention, Allegheny General Hospital, Pittsburgh, Pennsylvania, United States of America.; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, Pennsylvania, United States of America.
Weinshilboum R; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
Liu M; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2017 Oct 02; Vol. 13 (10), pp. e1007031. Date of Electronic Publication: 2017 Oct 02 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
BRCA1 Protein/*metabolism
Breast Neoplasms/*genetics
Cathepsins/*genetics
DNA-Binding Proteins/*genetics
BRCA1 Protein/genetics ; Breast Neoplasms/drug therapy ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cysteine Proteases/genetics ; Cysteine Proteases/metabolism ; Drug Resistance, Neoplasm/genetics ; Estrogen Receptor alpha/genetics ; Estrogen Receptor alpha/metabolism ; Female ; Gene Expression Regulation, Neoplastic ; Genetic Markers ; Genome-Wide Association Study ; Humans ; Polymorphism, Single Nucleotide ; Proteins ; Quantitative Trait Loci ; Tamoxifen/pharmacology
Czasopismo naukowe
Tytuł:
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer.
Autorzy:
Reese JM
Suman VJ
Subramaniam M
Wu X
Negron V
Gingery A
Pitel KS
Shah SS
Cunliffe HE
McCullough AE
Pockaj BA
Couch FJ
Olson JE
Reynolds C
Lingle WL
Spelsberg TC
Goetz MP
Ingle JN
Hawse JR; Department of Biochemistry and Molecular Biology, Mayo Clinic, 16-01B Guggenheim Building, 200 First St, SW, Rochester, MN 55905, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2014 Oct 07; Vol. 14, pp. 749. Date of Electronic Publication: 2014 Oct 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms/*metabolism
Breast Neoplasms/*pathology
Estrogen Antagonists/*pharmacology
Estrogen Receptor beta/*metabolism
Tamoxifen/*pharmacology
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/metabolism ; Breast Neoplasms/drug therapy ; Cell Line, Tumor ; Cell Nucleus/metabolism ; Cell Proliferation/drug effects ; Estrogen Receptor alpha/antagonists & inhibitors ; Estrogen Receptor beta/antagonists & inhibitors ; Estrogen Receptor beta/genetics ; Female ; Humans ; MCF-7 Cells ; Middle Aged
Czasopismo naukowe
Tytuł:
The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton.
Autorzy:
Gingery A; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America.
Subramaniam M; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America.
Pitel KS; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America.
Reese JM; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
Cicek M; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America.
Lindenmaier LB; Skeletal Biology Laboratory, School of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon, United States of America.
Ingle JN; Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.
Goetz MP; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.
Turner RT; Skeletal Biology Laboratory, School of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon, United States of America.
Iwaniec UT; Skeletal Biology Laboratory, School of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon, United States of America.
Spelsberg TC; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America.
Hawse JR; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 May 22; Vol. 9 (5), pp. e98219. Date of Electronic Publication: 2014 May 22 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents, Hormonal/*therapeutic use
Bone and Bones/*drug effects
Breast Neoplasms/*drug therapy
Tamoxifen/*analogs & derivatives
Animals ; Antineoplastic Agents, Hormonal/pharmacology ; Base Sequence ; DNA Primers ; Female ; Mice ; Mice, Inbred C57BL ; Ovariectomy ; Polymerase Chain Reaction ; Tamoxifen/pharmacology ; Tamoxifen/therapeutic use
Czasopismo naukowe
Tytuł:
Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells.
Autorzy:
Opyrchal M; Department of Medical Oncology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
Salisbury JL; Department of Biochemistry and Molecular Biology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
Zhang S; Department of Biochemistry and Molecular Biology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
McCubrey J; Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina, United States of America.
Hawse J; Department of Biochemistry and Molecular Biology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
Goetz MP; Department of Medical Oncology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
Lomberk GA; Department of Medical Oncology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
Haddad T; Department of Medical Oncology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
Degnim A; Department of General Surgery, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
Lange C; Departments of Medicine and Pharmacology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Ingle JN; Department of Medical Oncology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
Galanis E; Department of Medical Oncology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America; Department of Molecular Medicine, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
D'Assoro AB; Department of Medical Oncology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America; Department of Biochemistry and Molecular Biology, Mayo Clinic College Of Medicine, Rochester, Minnesota, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 May 09; Vol. 9 (5), pp. e96995. Date of Electronic Publication: 2014 May 09 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Drug Resistance, Neoplasm*
Aurora Kinase A/*metabolism
Breast Neoplasms/*metabolism
Breast Neoplasms/*pathology
Down-Regulation/*drug effects
Estrogen Receptor alpha/*metabolism
Hormones/*pharmacology
Animals ; Breast Neoplasms/enzymology ; Disease Progression ; Female ; Humans ; MCF-7 Cells ; Mice ; Smad5 Protein/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Pharmacogenomics of endocrine therapy in breast cancer.
Autorzy:
Ingle JN; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA. Ingle.james@mayo.edu
Pokaż więcej
Źródło:
Journal of human genetics [J Hum Genet] 2013 Jun; Vol. 58 (6), pp. 306-12. Date of Electronic Publication: 2013 May 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Breast Neoplasms/*drug therapy
Pharmacogenetics/*methods
Selective Estrogen Receptor Modulators/*therapeutic use
Anastrozole ; Androstadienes/therapeutic use ; Antineoplastic Agents, Hormonal/therapeutic use ; Aromatase Inhibitors/therapeutic use ; Breast Neoplasms/genetics ; Chemotherapy, Adjuvant ; Female ; Genome-Wide Association Study ; Humans ; Japan ; Letrozole ; Musculoskeletal Physiological Phenomena/drug effects ; Nitriles/therapeutic use ; Phenotype ; Postmenopause ; Raloxifene Hydrochloride/therapeutic use ; Randomized Controlled Trials as Topic ; Tamoxifen/therapeutic use ; Triazoles/therapeutic use
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies